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Abstract Post-stroke objective or subjective fatigue occurs
in around 50% of patients and is frequent (30%) even after
minor strokes. It can last more than one year after the event,
and is characterised by a different quality from usual
fatigue and good response to rest. Associated risk factors
include age, single patients, female, disability, depression,
attentional impairment and sometimes posterior strokes,
but also inactivity, overweight, alcohol and sleep apnoea
syndrome. There are few therapy studies, but treatment
may include low-intensity training, cognitive therapy, treat-
ment of associated depression, wakefulness-promoting
agents like modafinil, correction of risk factors and adapta-
tion of activities.
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Definition of fatigue
Fatigue is a multidimensional motor-perceptive, emotional
and cognitive experience. Objective fatigue corresponds
“to an observable and measurable decrement in perform-
ance occurring during the repetition of a physical or men-
tal task”, and subjective fatigue [1] is characterised by “a
feeling of early exhaustion, weariness and aversion to
effort”, and is nearer (although different) to neurasthenia
(ICD 10) and chronic fatigue syndrome (CFS). “Primary
fatigue syndrome” can also be distinguished from “sec-
ondary fatigue syndrome” [2] as it appears in the absence
of depression, significant cognitive alteration or any other
causes that could lead to fatigue, such as anti-hyperten-
sives, neuroleptics, antidepressants, decreased ferritine
level (<50 mg/l), lifestyle, obesity, addictions, infections
such as EBV or HIV, and depression (25%–30% of fatigue
in primary care). Post-stroke fatigue (PSF) is generally
thought to be a primary subjective fatigue but some partic-
ipating causes are often present. Cardiac disease, sleep
apnoea syndrome and vitamin D deficiency also increase
fatigue.
Frequency of post-stroke fatigue
Fatigue frequency in post-stroke survivors ranges from
29% to 68% (20% in the control groups) [3–5] and seems
to be correlated to functional disability and cognitive
impairment. The large variability across studies is probably
due to the inclusion criteria and the fatigue scales used.
Nevertheless, this symptom is also frequent (29%) after
minor strokes [6]. Particularly mental fatigue is also
observed even in the case of a single or small infarct.
Concerning time dynamics, PSF seems stable across
time. A longitudinal study showed some increased percent-
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ages of self-rated fatigue between admission (51.5%), 6
months (64.1%) and one-year (69.5%) follow-ups [5], sug-
gesting that fatigue may appear as activity increases. Two
thirds of tired patients at 6 months will continue to com-
plain from fatigue after 1 year. 
Characterisation of post-stroke fatigue
PSF is qualitatively different from the fatigue experienced
by patients before stroke. It is exacerbated by stress and
physical exercise, and responds well to rest, sleep and low
temperature (the last points being rarely described in CFS
or in depression). The severity scores are generally lower in
stroke patients than in matched multiple sclerosis (MS)
patients; moreover, PSF seems slightly more “physical”
and less “psychic” than MS-related fatigue [6]. PSF seems
to be favoured by disability, cognitive dysfunction, biogra-
phical factors (single before stroke, female gender, higher
age) and psychic post-stroke factors (depression, anxiety,
perception by the patient of having little control over his
health [6]). PSF can also be weakly influenced by lesion
site, particularly by posterior strokes [7]. Clinical cohort
analysis suggests that there are in fact different types of
fatigue in stroke: a “task-specific” fatigue linked to cogni-
tive or physical sequels (such as residual aphasia, when
mental fatigue appears after speaking for a certain length of
time) and a more “primary” PSF linked to subtle attention
difficulties after vertebro-basilar strokes impairing the cor-
tex activating system [1].
Since fatigue can be a key feature of depression, overlap
between both syndromes is unquestionable. In our cohort, the
presence of significant fatigue scores and depression criteria
6 months after stroke were predictors of depression at 12
months. Nevertheless, fatigue can also occur in the absence
of depression. For example, only 38% of patients with severe
fatigue after stroke met the criteria for depression [8].
Therapies of post-stroke fatigue
There are very few controlled studies on therapy of PSF.
Fluoxetine 20 mg/day does not improve PSF but it
decreases depressive symptoms [9]. Improvement of
sleep disordered breathing (with a CPAP) does not seem
to be effective in PSF unless the patients have a sympto-
matic sleep apnoea syndrome [10]. Recently, we con-
ducted a pilot study (40 patients with chronic stroke and
MS) with a wakefulness-promoting agent (modafinil).
Side effects led to a drop-out of 25% of patients. In the
remaining patients, preliminary results show that
modafinil decreased fatigue severity scores in MS and in
brain-stem or thalamic strokes, but not in cortical stroke
infarcts (Fig. 1). Such findings tend to confirm that PSF
characteristics may vary depending on aetiology and site
of lesions.
Studies on fatigue in cancer and CFS patients may
also provide some cues for PSF therapy. In 2006,
Gliessen and collaborators showed that cognitive behav-
ioural therapy (based on the model of precipitating and
perpetuating factors of post-cancer fatigue) has long-last-
ing positive effects on severely fatigued disease-free can-
cer patients [13]. In CFS patients, regular exercise train-
ing for 6 weeks (particularly low-intensity exercises)
decreased feelings of fatigue, independently from
changes in aerobic muscular parameters [14]. In conclu-
sion, there seem to be pharmacological and non-pharma-
cological cues to alleviate fatigue symptoms, but one of
the most important is the necessity to adapt patients’
activities. 
Fig. 1 Three-months pilot study
showing the differential effect of
modafinil on fatigue in patients
with posterior (brainstem or tha-
lamic) strokes and non-posterior
stroke (c2, p=0.01). Responder’s
profile was defined according to
the FAI (Fatigue Assessment
Inventory, Schwartz et al., 1993,
[11]) scores. Sleepiness was not
affected by therapy [12]P
atients com
pleting the study
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